Company Search:
Advanced Search
Sponsored Links
Chromadex Corporation Company Snapshot
Chromadex Corporation operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Chromadex with three other pharmaceutical manufacturers in North America: MedReleaf Corp of Canada (2016 sales of 19.30 million Canadian Dollars [US$15.52 million] of which 100% was Pharmaceutical), Fitlife Brands Inc ($25.31 million ), and Cyanotech Corporation ($31.84 million ).

Sales Analysis. During the year ended December of 2016, sales at Chromadex were $26.81 million. This is an increase of 21.8% versus 2015, when the company's sales were $22.01 million. This was the third consecutive year of growth at Chromadex. Sales of Ingredients Segments saw an increase of 33.7% in 2016, from $12.54 million to $16.77 million. Not all segments of Chromadex experienced an increase in sales in 2016: sales of Scientific and Regulatory Consulting Segme fell 36.8% to $665,444.00 . (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Chromadex Corporation
  Stock Performance Chart for Chromadex Corporation
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 5.85
(Figures in U.S. Dollars)
1 Week -5.3%   13 Weeks -2.8%  
4 Weeks 38.3%   52 Weeks 103.1%  
Chromadex Corporation Key Data:
  Ticker: CDXC Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 26,811,086
(Year Ending Jan 2017).
Employees: 93
  Currency: U.S. Dollars Market Cap: 314,712,760
  Fiscal Yr Ends: December Shares Outstanding: 53,797,053
  Share Type: Common Closely Held Shares: 23,300,014
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.